Dr. Kenneth Gollob studied molecular biology at the University of Colorado Boulder, and then completed a Ph.D. in Immunology and Microbiology at the University of Colorado Health Sciences Center and National Jewish Health in Denver, CO. His postdoctoral training was performed at DNAX Research Institute, Palo Alto, CA, with Dr. Robert Coffman on Th1/2 differentiation. Dr. Gollob has held positions as a Visiting Associate Professor and Visiting Scientist at Stanford University School of Medicine and the National Cancer Institute, National Institutes of Health, respectively. He was an Associate Professor at the Federal University of Minas Gerais (Brazil) and held research positions at SRI International (USA), and A.C.Camargo Cancer Center (Brazil). Currently, he leads a group focused on translational immunology in cancer and infectious diseases at Hospital Israelita Albert Einstein in São Paulo, Brazil. Dr. Gollob’s research interests include defining immune mechanisms and biomarkers of disease progression, adverse event development, and response to therapy in cancer and infectious diseases.